Jason N. Gorevic - Jun 2, 2020 Form 4/A - Amendment Insider Report for Teladoc Health, Inc. (TDOC)

Role
Chief Executive Officer, Director
Signature
/s/ Adam C. Vandervoort, attorney-in-fact
Stock symbol
TDOC
Transactions as of
Jun 2, 2020
Transactions value $
-$4,160,311
Form type
4/A - Amendment
Date filed
5/10/2021, 04:29 PM
Date Of Original Report
Jun 5, 2020
Next filing
Jun 2, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise $38.5K +23.1K +3.44% $1.67* 694K Jun 2, 2020 Direct F1, F2
transaction TDOC Common Stock Options Exercise $11.6K +1.93K +0.28% $6.01 696K Jun 2, 2020 Direct F1, F2
transaction TDOC Common Stock Sale -$265K -1.6K -0.23% $165.60* 695K Jun 2, 2020 Direct F1, F2, F3
transaction TDOC Common Stock Sale -$650K -3.9K -0.56% $166.73* 691K Jun 2, 2020 Direct F1, F2, F4
transaction TDOC Common Stock Sale -$824K -4.92K -0.71% $167.70* 686K Jun 2, 2020 Direct F1, F2, F5
transaction TDOC Common Stock Sale -$977K -5.79K -0.84% $168.80* 680K Jun 2, 2020 Direct F1, F2, F6
transaction TDOC Common Stock Sale -$1.32M -7.79K -1.15% $169.66* 672K Jun 2, 2020 Direct F1, F2, F7
transaction TDOC Common Stock Sale -$102K -600 -0.09% $170.41* 672K Jun 2, 2020 Direct F1, F2, F8
transaction TDOC Common Stock Sale -$17.1K -100 -0.01% $171.32* 672K Jun 2, 2020 Direct F1, F2
transaction TDOC Common Stock Sale -$51.8K -300 -0.04% $172.58* 671K Jun 2, 2020 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Employee Stock Option (right to buy) Options Exercise $0 -23.1K -100% $0.00* 0 Jun 2, 2020 Common Stock 23.1K $1.67 Direct F1, F2, F9
transaction TDOC Employee Stock Option (right to buy) Options Exercise $0 -1.93K -1.58% $0.00 120K Jun 2, 2020 Common Stock 1.93K $6.01 Direct F1, F2, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person was informed by the broker of the reported transactions on June 3, 2020. Accordingly, pursuant to Rule 16a-3(g)(2), the deemed execution date was June 3, 2020.
F2 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020.
F3 Represents the weighted average price of transactions ranging from $165.23 to $166.13, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 8 to this Form 4.
F4 Represents the weighted average price of transactions ranging from $166.24 to $167.11, inclusive.
F5 Represents the weighted average price of transactions ranging from $167.25 to $168.24, inclusive.
F6 Represents the weighted average price of transactions ranging from $168.27 to $169.26, inclusive.
F7 Represents the weighted average price of transactions ranging from $169.28 to $170.27, inclusive.
F8 Represents the weighted average price of transactions ranging from $170.31 to $170.51, inclusive.
F9 The option vested as to 25% of the shares on January 1, 2014. The remainder of the shares vested in 36 substantially equal monthly installments thereafter.
F10 The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vested in 36 substantially equal monthly installments thereafter.

Remarks:

Note: This Form 4 amendment is being filed to amend the previous Form 4 filed on June 5, 2020 to include the Deemed Execution Date of June 3, 2020, which was previously omitted.